Skip to content
Welcome, thoughtbot's Giant Robots listeners!Start here
Pandemics and Biosecurity
3OCT

Ebola case fatality crosses 40% in DRC

2 min read
13:42UTC

Africa CDC put Bundibugyo case fatality at 44.1% on 27 July, up from about 39.7% a week earlier, and attributes the rise to later presentation and saturated treatment sites.

ScienceDeveloping
Key takeaway

Bundibugyo now kills 44.1% of confirmed cases, driven by late presentation rather than the virus.

Case fatality among confirmed Bundibugyo Ebola cases in DR Congo reached 44.1% on 27 July, up from roughly 39.7% a week earlier, Africa CDC reported⁠1. The agency attributes the rise to patients arriving later and to treatment sites running full, not to any change in the pathogen. Its headline totals now stand at 3,380 confirmed cases and 1,489 deaths, against 2,344 and 930 seven days before.

Those totals need one caveat carried alongside them. Africa CDC's own chart note marks the 22 July step change as retrospective harmonisation with the Ituri and North Kivu case registers rather than a single-day surge⁠2. Read off the chart gridlines, the back-filled portion runs somewhere near 350 to 400 cases, an estimate rather than a figure the agency states. A meaningful share of the apparent week is therefore old cases arriving late in the ledger, and the raw difference between the two totals overstates how fast the epidemic moved.

Readers reaching for the 2018-20 Kivu epidemic as a yardstick will reach wrong. Kivu killed about 66% of those it infected, but Kivu was Zaire ebolavirus, a different species from the Bundibugyo ebolavirus circulating now. Bundibugyo has two earlier outbreaks in the literature: Uganda in 2007, with 131 cases and 39 deaths, and Isiro in eastern DRC in 2012, with 38 cases and 13 deaths, close to 30% in the first and 34% in the second. Measured against Kivu, 44.1% looks merciful. Measured against its own species, it runs ten points above anything Bundibugyo has done before, and the drift from 39.7% in seven days is the part that should concern anyone reading the trend rather than the level. Isolation coverage was already near 44% when WHO put cases at 1,481 in early July; untreated Ebola kills at rates no species comparison can soften.

Deep Analysis

In plain English

Case-fatality rate means the share of confirmed patients WHO die from the disease. It has climbed from about 40% to 44% in a week. Africa CDC says this is not because the virus has become more dangerous, but because sick people are reaching treatment later and the treatment sites they do reach are overloaded. Getting care quickly matters enormously with Ebola, so anything that delays it, whether that is distance, an overwhelmed hospital, or a shortage of isolation beds, translates directly into more deaths among the people WHO do get diagnosed.

Deep Analysis
Root Causes

Case-fatality in a filovirus outbreak rises when the interval between symptom onset and clinical care lengthens, because supportive treatment, fluids, electrolyte correction and organ support, is time-sensitive; a patient reaching a saturated treatment site late in the disease course has a materially worse prognosis than one admitted early, independent of the virus itself.

Treatment-site saturation compounds this: the same bed-capacity imbalance straining Nord-Kivu and the same testing bottleneck consuming isolation beds nationally both push presentation and admission later in the disease course, which is why Africa CDC links the case-fatality rise to logistics rather than pathogen change.

What could happen next?
  • Meaning

    The rise from 39.7% to 44.1% case-fatality is attributed by Africa CDC to system strain, later presentation and saturated sites, not to a change in Bundibugyo ebolavirus's underlying lethality.

  • Consequence

    A rising case-fatality rate driven by system strain will likely track the same bed-misallocation and testing-delay problems documented elsewhere in this update, rather than resolve independently.

First Reported In

Update #12 · Two-thirds of Ebola deaths never reach a ward

Africa CDC· 31 Jul 2026
Read original →
Different Perspectives
IGWG co-chair Tovar da Silva Nunes
IGWG co-chair Tovar da Silva Nunes
The Brazilian co-chair closed the eighth pathogen-sharing session on 18 September without an agreed annex text, the second session in a row to end that way. He presented the outcome as continued commitment, with adoption due at the World Health Assembly in May 2027.
Fraport
Fraport
The Frankfurt Airport operator has told staff to watch for fever, hessenschau reported, after six airport workers caught malaria. Germany does not require insecticide spraying of arriving aircraft cabins, and parasite genotyping to trace the source is due at the end of October.
European Centre for Disease Prevention and Control
European Centre for Disease Prevention and Control
ECDC reported the eight Frankfurt Airport malaria cases on 18 September and considers repeated arrivals of infected mosquitoes on aircraft likely. It has not ruled out local mosquitoes, and awaits genotyping due at the end of October.
Pan American Health Organization
Pan American Health Organization
PAHO counted 53,957 measles cases in the Americas by 19 September and is supporting Peru's response in Puno and Arequipa. It warns that October's Señor de los Milagros festivities and Pope Leo XIV's November visit could increase transmission.
Bangladesh Directorate General of Health Services
Bangladesh Directorate General of Health Services
The DGHS recorded 1,030 measles-related deaths and 172,720 suspected cases by 14 September, after a campaign that reached 19.75 million children. Its disease-control director, Halimur Rashid, said further vaccination rounds were expected within two weeks.
Minapharm
Minapharm
The Egyptian drugmaker and its Berlin subsidiary ProBioGen were awarded up to US$16.5m by CEPI on 27 August to take a Bundibugyo vaccine into a Phase 1 trial in Africa. Final manufacture is planned for Cairo, making it CEPI's first Bundibugyo candidate with an African producer.